US Group Raises Pricing Recommendation For Gilead's Remdesivir In COVID

Gilead Sciences Inc's antiviral remdesivir could be priced up to $5,080 per course based on benefits shown in COVID-19 patients, a U.S. drug pricing research group suggested on Wednesday, above its...

from NDTV News - Latest https://ift.tt/3hX2lsF

Comments

Popular posts from this blog

Gurugram Man Kidnaps Toddler For Childless Sister, Arrested: Cops

Cannes 2024: Sobhita Adds Sparkle And Glam. See French Riviera Album